Holocarboxylase Synthetase (HLCS) Deficiency: A Patient Guide

IMPORTANT: This guide does not replace your child’s individualized written metabolic emergency plan. Keep that plan, your prescribed biotin, and your specialist’s contact information accessible at all times, including when traveling.

Holocarboxylase Synthetase (HLCS) deficiency is a rare genetic condition that affects how your child’s body uses a vital B-vitamin called biotin. In a healthy body, the HLCS enzyme acts as a helper that attaches biotin to several other enzymes responsible for breaking down proteins, fats, and carbohydrates from food. Without this process, these enzymes cannot function, and the body begins to accumulate harmful acidic byproducts in the blood and urine ^[1][2]. While hearing this diagnosis can be frightening, HLCS deficiency often responds very well when treated promptly, and children can go on to live active, full lives ^[3][4].

The foundation of managing this condition is lifelong, high-dose biotin therapy. Because the body’s natural process for using biotin is impaired, providing it in a concentrated oral supplement bypasses the metabolic “roadblock.” This treatment is highly effective, often correcting dangerous chemical imbalances rapidly ^[5][6]. Many children who begin treatment early and take their biotin consistently every day achieve stable health and steady physical and brain development ^[3].

Despite the success of biotin, parents must remain alert during times of physical stress, such as when a child is sick with a fever, a stomach virus, or is unable to eat. These situations can lead to a metabolic crisis, where the body’s chemistry becomes dangerously unstable ^[7][8]. By working closely with a metabolic specialist, you will learn an individualized “sick-day plan” to help prevent these crises and know exactly when to seek emergency care ^[7].

Navigating a rare diagnosis is a journey, but you are not alone. Your medical team will provide the guidance needed to monitor your child’s health through routine lab tests and developmental checks ^[3][5]. With consistent treatment, awareness of laboratory interferences, and a proactive approach to illness, the outlook for children with HLCS deficiency is bright ^[3][4].